BIOENSIS 2D/3D Oncolytic Virus Tumor Cell Line Profiling offers a robust and systematic approach to evaluate the efficacy of oncolytic viruses across a diverse panel of cancer cell lines. This platform enables comprehensive screening to assess viral potency and tumor selectivity. Our advanced 2D and 3D culture systems are engineered to replicate key aspects of the tumor microenvironment, including cellular architecture, metabolic gradients, and matrix composition. These physiologically relevant conditions provide more predictive insights into how oncolytic viruses will perform in vivo, supporting more informed decision-making in early-stage development. By closely modeling the complexity of human tumors, BIOENSIS’ profiling platform reduces the likelihood of false positives or negatives and increases the confidence in selecting the most promising therapeutic candidates.
Key features:
• Over 150 target tumor cell lines available for testing
• Cell viability determined by ATP measurement
• Models tested in a high throughput format
• Precision IC50, EC50, and GI50 results
• Flexible testing protocols including single and combination agents
• Available in 2D and 3D cultures
Please contact us to discuss your study and an up to date list of available cell lines info@bioensis.com
